Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- New effective and safe antifungal isolated from sea squirt microbiomeon November 20, 2020 at 6:20 am
By combing the ocean for antimicrobials, scientists have discovered a new antifungal compound that efficiently targets multi-drug-resistant strains of deadly fungi without toxic side effects in mice.
- Sea Squirt Microbiome Yields Compound Effective against Deadly Strain of Fungal Pathogenon November 20, 2020 at 4:00 am
Newly identified antifungal compound, turbimicin, found to be safe at high doses in mice, and demonstrated a fungal-specific mode of action.
- Children’s immature immune systems threatened by increasing ‘superbugs’on November 20, 2020 at 1:25 am
Infants and toddlers love to crawl on the ground and put their fingers in their mouths, but their immature immune systems render them more susceptible to diseases, including those caused by ...
- New effective and safe antifungal isolated from sea squirt microbiomeon November 19, 2020 at 11:02 am
Nearly half of patients with systemic Candida infection ... all fungal strains at low concentrations, indicating a potent effect. Similar experiments in mice infected with drug-resistant strains ...
- New effective and safe antifungal isolated from sea squirt microbiomeon November 19, 2020 at 11:00 am
The new molecule was discovered in the microbiome of a sea squirt from the Florida Keys as part of an effort to identify novel antimicrobials from understudied ecosystems. Scientists named the ...
- Drugs from bugs in creatures of the seaon November 19, 2020 at 10:47 am
Turbinmicin reduced fungal burden in mouse models of drug-resistant fungal infection caused by Candida auris and Aspergillus fumigatus and was well tolerated in mice. The benefit of turbinmicin ...
- European Research Council Awards €10 Million Collaborative Grant to Israeli, German Researcherson November 16, 2020 at 6:50 am
While most fungal infections are not life-threatening ... pathogens is fundamentally different from the situation with drug-resistant bacteria,” said professor Berman, according to the statement.
- €10m. grant given to Israeli researchers studying fungal infectionson November 15, 2020 at 3:17 pm
Fungal infections cause at least 1.6 million deaths ... pathogens is fundamentally different from the situation with drug-resistant bacteria," said Prof. Judith Berman, who is head of the Fungal ...
- Collagen Crosslinking Shows Promise for Keratitison November 15, 2020 at 8:29 am
The procedure could prove particularly useful in treating drug-resistant pathogens ... Ultraviolet light has long been used to treat blood infections, so the idea of using it for keratitis ...
- ERC awards joint synergy grant to researchers from Tel Aviv university and Charité – Universitätsmedizin Berlinon November 14, 2020 at 4:00 pm
The goal of the 10 Million Euro grant is to inspire the development of new antifungal drugs and combination therapies that will be effective against lethal invasive fungal infections.
via Bing News